Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clint Cary

Showing results (61-70 of 123) with videos related to

Pageof 13
Sort By:
The Journal of Urology|November 12, 2020
Surgical Management of Retrocrural Disease in Germ Cell Tumors: Outcomes and Evolution of PracticeSean Q Kern, Clint Cary, Hristos Z Kaimakliotis, et al.
BJU International|April 10, 2014
Limited ability of existing nomograms to predict outcomes in men undergoing active surveillance for prostate cancerSiao-Yi Wang, Janet E Cowan, K Clint Cary, et al.
The Journal of Urology|May 13, 2014
Survival analysis of pure seminoma at post-chemotherapy retroperitoneal lymph node dissectionKevin R Rice, Stephen D W Beck, Richard Bihrle, et al.
Clinical Genitourinary Cancer|November 7, 2017
Long-Term Survival of Good-Risk Germ Cell Tumor Patients After Postchemotherapy Retroperitoneal Lymph Node Dissection: A Comparison of BEP × 3 vs. EP × 4 and Treating InstitutionClint Cary, Joseph M Jacob, Costantine Albany, et al.
Urology|November 15, 2016
Management of Pelvic Metastases in Patients With Testicular CancerJoseph M Jacob, Raul Mehan, Stephen D W Beck, et al.
Journal of Robotic Surgery|October 1, 2020
Xanthogranulomatous pyelonephritis: a comparison of open and minimally-invasive surgical approachesMarcelo Panizzutti Barboza, Charles U Nottingham, Adam C Calaway, et al.
Urologic Oncology|December 3, 2014
Contemporary bladder cancer: variant histology may be a significant driver of diseaseM Francesca Monn, Hristos Z Kaimakliotis, Jose A Pedrosa, et al.
Urology|August 2, 2015
Risk of Recurrence for Clinical Stage I and II Patients With Teratoma Only at Primary Retroperitoneal Lymph Node DissectionNick W Liu, Clint Cary, Andrew C Strine, et al.
Cancer|September 16, 2015
Outcomes of postchemotherapy retroperitoneal lymph node dissection following high-dose chemotherapy with stem cell transplantationClint Cary, Jose A Pedrosa, Joseph Jacob, et al.
Clinical Genitourinary Cancer|April 23, 2023
Late Relapse of Germ Cell Tumors After Prior Chemotherapy or Surgery-onlyNoah H Richardson, Sandra K Althouse, Ryan Ashkar, et al.
Pageof 13

Showing results (61-70 of 123) with videos related to

Sort By:
Pageof 13
The Journal of Urology|November 12, 2020
Surgical Management of Retrocrural Disease in Germ Cell Tumors: Outcomes and Evolution of PracticeSean Q Kern, Clint Cary, Hristos Z Kaimakliotis, et al.
BJU International|April 10, 2014
Limited ability of existing nomograms to predict outcomes in men undergoing active surveillance for prostate cancerSiao-Yi Wang, Janet E Cowan, K Clint Cary, et al.
The Journal of Urology|May 13, 2014
Survival analysis of pure seminoma at post-chemotherapy retroperitoneal lymph node dissectionKevin R Rice, Stephen D W Beck, Richard Bihrle, et al.
Clinical Genitourinary Cancer|November 7, 2017
Long-Term Survival of Good-Risk Germ Cell Tumor Patients After Postchemotherapy Retroperitoneal Lymph Node Dissection: A Comparison of BEP × 3 vs. EP × 4 and Treating InstitutionClint Cary, Joseph M Jacob, Costantine Albany, et al.
Urology|November 15, 2016
Management of Pelvic Metastases in Patients With Testicular CancerJoseph M Jacob, Raul Mehan, Stephen D W Beck, et al.
Journal of Robotic Surgery|October 1, 2020
Xanthogranulomatous pyelonephritis: a comparison of open and minimally-invasive surgical approachesMarcelo Panizzutti Barboza, Charles U Nottingham, Adam C Calaway, et al.
Urologic Oncology|December 3, 2014
Contemporary bladder cancer: variant histology may be a significant driver of diseaseM Francesca Monn, Hristos Z Kaimakliotis, Jose A Pedrosa, et al.
Urology|August 2, 2015
Risk of Recurrence for Clinical Stage I and II Patients With Teratoma Only at Primary Retroperitoneal Lymph Node DissectionNick W Liu, Clint Cary, Andrew C Strine, et al.
Cancer|September 16, 2015
Outcomes of postchemotherapy retroperitoneal lymph node dissection following high-dose chemotherapy with stem cell transplantationClint Cary, Jose A Pedrosa, Joseph Jacob, et al.
Clinical Genitourinary Cancer|April 23, 2023
Late Relapse of Germ Cell Tumors After Prior Chemotherapy or Surgery-onlyNoah H Richardson, Sandra K Althouse, Ryan Ashkar, et al.
Pageof 13